肾毒性
医学
庆大霉素
急性肾损伤
万古霉素
阿米卡星
低出生体重
人口
妥布霉素
儿科
内科学
抗生素
毒性
怀孕
遗传学
环境卫生
细菌
微生物学
生物
金黄色葡萄球菌
作者
Erika T. Rhone,J. Bryan Carmody,Jonathan R. Swanson,Jennifer R. Charlton
标识
DOI:10.3109/14767058.2013.860522
摘要
To quantify exposure to potentially nephrotoxic medications among very low birth weight (VLBW) infants and determine the relationship of nephrotoxic medication exposure to acute kidney injury (AKI) in this vulnerable population.We reviewed 107 VLBW infants who survived to discharge from April 2011 to March 2012 and measured exposure to the following nephrotoxic medications: acyclovir, amikacin, amphotericin B, gentamicin, ibuprofen, indomethacin, iohexol, tobramycin and vancomycin. Acute kidney injury was determined by the KDIGO guidelines.Exposure to ≥ 1 nephrotoxic medication occurred in 87% of infants. The most common exposures were gentamicin (86%), indomethacin (43%) and vancomycin (25%). There was an inverse linear relationship between birth weight and nephrotoxic medications received per day (R(2) = 0.169, p < 0.001). Infants with AKI received more nephrotoxic medications per day than those who did not (0.24 versus 0.15; p = 0.003).VLBW infants are frequently exposed to nephrotoxic medications, receiving approximately two weeks of nephrotoxic medications before discharge or 1 for every 6 d of hospitalization. The greatest exposure occurred among the smallest, most immature infants and those who experienced AKI.
科研通智能强力驱动
Strongly Powered by AbleSci AI